两种化疗方案治疗初治多发性骨髓瘤的成本-效果分析

Cost-utility analysis of dexamethasone combined with bortezomib and lenalidomide in the treatment of newly diagnosed multiple myeloma

Cost-effectiveness analysis of serplulimab combined with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma

胸腺五肽联合TP方案治疗晚期非小细胞肺癌的成本-效果分析

丹参川芎嗪注射液联合厄贝沙坦治疗糖尿病肾病的成本-效果分析

School of International Pharmaceutical Business， China Pharmaceutical University